Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 3 August 2026.
Announcements
1,961
Total raised
£9.3B
disclosed amounts
Fasanara Capital has backed the London fintech as it develops its asset tokenisation platform.
"Since 2017, our focus has been on real-world asset tokenisation where we see growing interest. Our partnership with Fasanara is a step towards developing reliable DeFi yield mechanisms, broadening the investment possibilities in crypto but also helping to mitigate its inherent volatilities, all while striving to make finance more accessible around the world."
The seed round was co-led by Portage and Backed to support international expansion and product development.
"Lopay’s mission has resonated with thousands of small businesses and sole traders who are being squeezed simultaneously by high inflation and fragile customer demand."
The seed round was led by Mark Boost with backing from Green Angel Ventures and British Gas.
"Data centres are fundamental to our modern lives but they do use (and waste) enormous amounts of energy. All the processing energy ends up as heat and more energy is spent getting rid of it. But heat is useful, why waste it? At heata we’re reusing it to help tackle fuel poverty in a cost of living crisis; another key challenge of our time. This enables a step change in sustainable compute with a genuine social impact."
The seed round was led by HV Capital with participation from Dutch Founders Fund, AlbionVC, FFVC, and other backers.
"Lenders are really just at the start of the digitalisation journey. kennek is here to help accelerate that journey and provide them with the tools to capitalise on the growth of the non-bank lending space."
Abbey International Finance and Ryan Group Holdings have backed Cisiv to scale its operations and enhance its Baseline Plus software.
"We have seen a transformation of the market and a recognition that technology solutions can help deliver evidence more efficiently. We are thrilled to see the uptake of Baseline Plus to enable market access, real-world evidence for health outcomes and patient reported outcomes. This new funding will help us to scale our operations and commercial teams to help deliver real-world data to more life science partners."
